Panel discussion on severe/near-fatal asthma exacerbations in childhood - 21 OCTOBER, 2025

Panel discussion on severe/near-fatal asthma exacerbations in childhood - 21 OCTOBER, 2025

Additional content

Slides

21 October, 2025 | Online
17:00-18:00 CEST

 

Chairs: Dr Niels W. Rutjes (Amsterdam, Netherlands), Prof. Stéphanie Lejeune (Lille, France)

Speaker: Prof. Steve Cunningham (Edinburgh (Scotland), United Kingdom), Dr Andrew Nyman (London, United Kingdom)

 

Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member

Overview

Asthma continues to be a potentially fatal condition in children and adolescents. Modifiable risk factors are often present, highlighting opportunities for prevention. Timely recognition and effective management of severe asthma exacerbations are critical to reducing the risk of death. This webinar will focus on the recently developed consensus definition of near-fatal asthma and will address the acute management of life-threatening exacerbations in the emergency department and pediatric intensive care unit.

Topics:

  • Consensus definition of near-fatal asthma in childhood
  • Early recognition of children at risk for severe exacerbations
  • Management of severe and life-threatening asthma exacerbations

Format

One-hour webinar format: 45 minutes for presentation, followed by a 15-minute Q&A session.

Learning outcomes

Following this webinar, participants will be able to:

  • Apply recently published consensus definition of near-fatal asthma in childhood with a focus on the early recognition and identification of pediatric patients at increased risk for developing life-threatening asthma exacerbations. Prompt and accurate identification of such patients is critical to reducing morbidity and preventing poor clinical outcomes.
  • Apply alternative pharmacological treatment modalities in patients with severe, life-threatening asthma exacerbations who show insufficient improvement with standard therapies such as salbutamol and prednisolone. Use of alternative treatment modalities may prevent the need for intensive care admission/(non)invasive ventilatory support.

CME credit

An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.

What is a webinar?

A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.

Login guidelines

More information will be communicated in due course.

  • Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
  • Check Central European Summer Time.
  • To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
  • Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.

Diseases/methods:

  • Airway diseases
  • Paediatric respiratory diseases

Target audience

  • Clinicians
  • Trainees and fellows
  • Allied health professionals